Navigation Links
Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
Date:5/27/2009

09 and December 31, 2008 23,241 23,241 Additional paid-in capital 10,430,168 10,430,168 Statutory reserves 1,776,634 1,585,383 Retained earnings 12,634,436 10,996,655 Accumulated other comprehensive income 250,477 237,658 Total Stockholders' Equity 25,114,956 23,273,105 Total Liabilities and Stockholders' Equity $31,292,782 $28,997,639 BIOSTAR PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Three Months Ended March 31, 2009 2008 Sales, net $7,447,664 $6,810,259 Cost of sales 2,658,807 2,638,679 Gross profit 4,788,857 4,171,580 Selling, general and administrative expenses 2,479,984 2,052,678 Income from operations 2,308,873 2,118,902 Other Income (Expense) Interest income 310 79 Interest expense -- (13,953) Total other Income (Expense) 310 (13,874) Income before income taxes 2,309,183 2,105,028 Provision for income taxes 480,151 283,898 Net income $1,829,032 $1,821,130 Net income per common share
'/>"/>
SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
3. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
4. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
5. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
6. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
7. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
8. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
9. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
10. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
11. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 On ... H.R. 83, the Omnibus and Continuing Resolution Appropriations Act ... a condition eligible to receive funding through the Congressionally ... of Defense (DoD). The Hydrocephalus Association (HA), working in ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... been granted a new patent on its technology for using ... cells. Platypus is a nanotechnology company with 21 employees that ... , , View the patent , , Previous ... board of directors , , Platypus Technologies receives ...
... Ever since the Trojans hauled that giant wooden statue ... of armed Greeks in the streets, people have been ... that careful policy - within reason. , ,The state ... it considers a landmark plan to build the first ...
... — Third Wave Technologies, Inc. has ... an attorney that helped litigate Third Wave's successful patent ... announced that it would host a conference call on ... first quarter earnings. , ,Third Wave, which develops and ...
Cached Biology Technology:Seven good reasons to approve the Institutes for Discovery 2Seven good reasons to approve the Institutes for Discovery 3Third Wave announces two senior management appointments 2
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
(Date:12/22/2014)... Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces it has ... for the 2015 International CES debut of the Wocket™ ... will be at the NXT-ID booth January 6th and 7 ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... the University of Illinois at Urbana-Champaign have demonstrated for ... used to trap, manipulate, and probe nanoparticles, including fragile ... plasmonic nanoantennas enhance local fields by up to several ... can use these structures with a regular CW laser ...
... discovery of a new gene could lead to better ... and appearing on the cover of this week,s ... that domestic tomatoes could re-learn a thing or two ... to tomato crops losing beneficial traits common to wild ...
... papers posted online from 20 July through 14 ... Turkey, Nova Scotia, Switzerland, New Mexico, and the U.S. ... age dating using zircon crystals, the Code of Stratigraphic ... GSA Bulletin articles published ahead of print are ...
Cached Biology News:Newly demonstrated capabilities of low-powered nanotweezers may benefit cellular-level studies 2New gene could lead to better bug-resistant plants 2Summer Geoscience from GSA Bulletin 2Summer Geoscience from GSA Bulletin 3Summer Geoscience from GSA Bulletin 4Summer Geoscience from GSA Bulletin 5Summer Geoscience from GSA Bulletin 6Summer Geoscience from GSA Bulletin 7Summer Geoscience from GSA Bulletin 8Summer Geoscience from GSA Bulletin 9Summer Geoscience from GSA Bulletin 10Summer Geoscience from GSA Bulletin 11Summer Geoscience from GSA Bulletin 12Summer Geoscience from GSA Bulletin 13Summer Geoscience from GSA Bulletin 14Summer Geoscience from GSA Bulletin 15
Includes USB cable, custom driver and one roll of thermal paper...
Newborn Bovine Serum Heat-Inactivated...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
Biology Products: